Arrowstreet Capital, Limited Partnership Nevro Corp Transaction History

Arrowstreet Capital, Limited Partnership

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$141.6 - $179.06 $4.66 Million - $5.89 Million	-32,906 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$132.81 - $182.18 $3.52 Million - $4.83 Million	26,506 Added 414.16%	32,906 $4.59 Million
Q4 2020 Feb 12, 2021	BUY	$138.17 - $184.34 $884,287 - $1.18 Million	6,400 New	6,400 $1.11 Million
Q2 2020 Aug 12, 2020	SELL	$89.45 - $129.85 $2.46 Million - $3.57 Million	-27,489 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$70.23 - $144.31 $1.93 Million - $3.97 Million	27,489 New	27,489 $2.75 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.